David Tuveson, MD, PhD, will join Duke Health as executive director of the Duke Cancer Institute (DCI), effective October 31, 2026. Tuveson, a preeminent cancer biologist, is currently the Roy J. Zuck...

Scott Atlas wants to abolish the National Institutes of Health and let markets take over ("NIH is a government weapon for political power. Abolish it," Washington Post, July 2).

In this DocTalk, Dr. Nicholas DeVito from Duke Cancer Institute talks to us about the new treatment everyone is excited about: bispecific antibodies. Watch this DocTalk to learn more! If you are a stage 4 CRC patient and are interested in clinical trials--by the way, there are clinical trials with bispecific antibodies and standard of care chemo therapy for newly diagnosed patients-- This DocTalk is a must-watch! Subscribe to the Paltown Channel, so you'll be the 1st to hear about new Doctalks! Visit Colontown University Lecture Hall for other DocTalks https://learn.colontown.org/learningcenter/lecture-hall/

YouTube video by Visionary Music Group

Nature - Reliance on artificial-intelligence tools degrades the abilities of physicians and software engineers, studies show.

Current therapies offer limited benefit for patients with previously treated metastatic pancreatic ductal adenocarcinoma (mPDAC). Aberrant activation of the RAS pathway is the key driver of PDAC, w...

Office of Management and Budget Director Russell Vought has poured gas on the foundations of science. Pharma CEOs should demand that President Donald Trump...

Trump's Russ Vought Is Trying To Kill American Science. We Can Try To Stop Him, by Shouldn't Need to Be a Lawyer by Matthew Cortland on Patreon. Join Shouldn't Need to Be a Lawyer by Matthew Cortland...

Budget proposal would also curb federal payments for scientific publishing.

US science funder once again restricts awards to Harvard University and other research institutions.

Duke has won federal funding to lead a national HIV vaccine research consortium since 2005. Now the National Institutes of Health is ending its grant.

YouTube video by DukeCancerInstitute

We spoke with North Carolina doctors about how to mitigate risk of colon cancer, and new treatments.

Rates of rectal cancer deaths are rising in adults under 50.

In a trial, metastatic pancreatic cancer patients on the medicine lived twice as long as those on chemotherapy.

The Yvonne Awards, symbolizing the strength and longevity of the yew tree, honors exceptional achievements in oncology with its unique Y-shaped sculpture that

Forecast by science-policy researchers raises questions about where the epicentre of global research will shift to in the coming decade.

Our laboratory and clinical research program is focused on understanding the mechanisms that colorectal cancer and other gastrointestinal cancers use to evade the immune system during metastasis, or s...

Spencer Laird was diagnosed with colon cancer at 26. At 30, he was told it had returned and spread to his lungs, with one tumor the size of a golf ball.

Leadership in the Public Health Service must remain merit-based and above politics.

Welcome to My Personal Page

The conjugation of glycoproteins and glycolipids with the dietary sugar L-fucose is known as fucosylation. In this Progress article, Bitaraf et al. describe the latest work showing how fucosylation is deregulated in cancer, influencing tumour progression and therapeutic responses, and how it might be leveraged to treat cancer.

Dozens of drugs can alter the immune system and affect activity of immune checkpoint inhibitors

DURHAM, N.C. – Immunotherapy is offering new hope for cancers that once had grim prognoses by harnessing the body’s own immune system to fight the disease, often sparing patients from the harsh side e...